Ceryvyn Therapeutics Ltd CKDXF
Trading Information
- Previous Close Price
- $0.44
- Day Range
- $0.01–0.01
- 52-Week Range
- $0.01–0.01
- Bid/Ask
- $0.00 / $0.01
- Shares Outstanding
- 1.37B
- Market Cap
- $12.31M
- Volume/Avg
- 50,000 / 50,000
Key Statistics
- Price/Earnings (Normalized)
- 0.24
- Price/Sales
- —
- Dividend Yield (Trailing)
- 0.00%
- Dividend Yield (Forward)
- 0.00%
- Dividend Payment Schedule
- —
- Total Yield
- —
Company Profile
Ceryvyn Therapeutics Ltd is an Australian biotechnology company developing a biologic therapy for the rare disease LAM (lymphangioleiomyomatosis). It is engaged in the investigation of CYV-101 as a potential treatment for Lymphangioleiomyomatosis (LAM). It operates in one segment, being the biotechnology and healthcare industry in Australia.
- Sector
- Healthcare
- Industry
- Biotechnology
- Stock Style Box
- Small Value
- Total Number of Employees
- 10
- Website
- https://www.ceryvyn.com
Valuation
|
Metric
|
CKDXF
|
|---|---|
Price/Earnings (Normalized) | 0.24 |
Price/Book Value | 0.67 |
Price/Sales | — |
Price/Cash Flow | — |
Price/Earnings
CKDXF
Financial Strength
|
Metric
|
CKDXF
|
|---|---|
Quick Ratio | 13.43 |
Current Ratio | 13.78 |
Interest Coverage | 30.77 |
Quick Ratio
CKDXF
Profitability
|
Metric
|
CKDXF
|
|---|---|
Return on Assets (Normalized) | 137.52% |
Return on Equity (Normalized) | — |
Return on Invested Capital (Normalized) | 177.67% |
Return on Assets
CKDXF
Biotechnology Industry Comparables
|
1-Day Chart
|
Name
|
Price
|
Morningstar Rating for Stocks
|
Capital Allocation
|
Economic Moat
|
Market Cap
|
|---|---|---|---|---|---|---|
| Vertex Pharmaceuticals Inc
VRTX
| LOCK|>R><&# | LOCK|&$%C | $127B | |||
| Regeneron Pharmaceuticals Inc
REGN
| LOCK|NBVWs? | LOCK|l^<m | $76B | |||
| Moderna Inc
MRNA
| LOCK|#%Rwn! | LOCK|GH | $75B | |||
| argenx SE ADR
ARGX
| LOCK|&nC!vy | LOCK|C!# | $59B | |||
| BeOne Medicines Ltd ADR
ONC
| LOCK|<bH&?k@ | LOCK|Y^h | $43B | |||
| Alnylam Pharmaceuticals Inc
ALNY
| LOCK|GMM^G#Y | LOCK|^<#!n | $30B | |||
| Royalty Pharma PLC Class A
RPRX
| LOCK|M<QV%#J$ | LOCK|tM&W | $25B | |||
| BioNTech SE ADR
BNTX
| LOCK|d@<s!k< | LOCK|vH& | $24B | |||
| Incyte Corp
INCY
| LOCK|xRRPWhF | LOCK|&x | $23B | |||
| Jazz Pharmaceuticals PLC
JAZZ
| LOCK|>&m<Lw | LOCK|>BK | $15B |
United States